Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)
Clinical trial NCT04569786 · TERMINATED
Trial details
- NCT number
- NCT04569786
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2021-02-18
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.